Samuel Ebong

1.2k total citations
17 papers, 984 citations indexed

About

Samuel Ebong is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Samuel Ebong has authored 17 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Samuel Ebong's work include Immune Response and Inflammation (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Sepsis Diagnosis and Treatment (4 papers). Samuel Ebong is often cited by papers focused on Immune Response and Inflammation (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Sepsis Diagnosis and Treatment (4 papers). Samuel Ebong collaborates with scholars based in United States and China. Samuel Ebong's co-authors include Daniel G. Remick, Douglas R. Call, Jean A. Nemzek, David E. Newcomb, G. Bolgos, Charles E. Egwuagu, Cheng‐Rong Yu, Rashid M. Mahdi, Sharon H. Jackson and Barbara P. Vistica and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Critical Care Medicine.

In The Last Decade

Samuel Ebong

17 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Ebong United States 13 591 233 223 187 131 17 984
C M Buresh United States 9 549 0.9× 283 1.2× 112 0.5× 223 1.2× 113 0.9× 11 1.2k
Robert M. Strieter United States 9 524 0.9× 110 0.5× 231 1.0× 181 1.0× 266 2.0× 10 1.0k
Lyuba Miteva Bulgaria 20 459 0.8× 164 0.7× 272 1.2× 223 1.2× 81 0.6× 56 1.0k
Kurt D. Bernacki United States 9 384 0.6× 196 0.8× 70 0.3× 176 0.9× 111 0.8× 15 695
Hidetoshi Seki Japan 16 456 0.8× 123 0.5× 153 0.7× 393 2.1× 68 0.5× 30 1.0k
Grace Y. Song United States 14 477 0.8× 253 1.1× 60 0.3× 226 1.2× 96 0.7× 25 774
K. Guo United States 11 639 1.1× 140 0.6× 155 0.7× 253 1.4× 313 2.4× 13 1.2k
Cees J. van der Linden Netherlands 15 309 0.5× 268 1.2× 67 0.3× 158 0.8× 101 0.8× 20 792
Eline Dejonckheere Belgium 9 369 0.6× 289 1.2× 134 0.6× 334 1.8× 136 1.0× 11 1.2k
Edward J. Pulido United States 15 333 0.6× 153 0.7× 68 0.3× 272 1.5× 176 1.3× 23 810

Countries citing papers authored by Samuel Ebong

Since Specialization
Citations

This map shows the geographic impact of Samuel Ebong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Ebong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Ebong more than expected).

Fields of papers citing papers by Samuel Ebong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Ebong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Ebong. The network helps show where Samuel Ebong may publish in the future.

Co-authorship network of co-authors of Samuel Ebong

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Ebong. A scholar is included among the top collaborators of Samuel Ebong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Ebong. Samuel Ebong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Egwuagu, Charles E., et al.. (2007). Cytokine-Induced Retinal Degeneration: Role of Suppressors of Cytokine Signaling (SOCS) Proteins in Protection of the Neuroretina. Advances in experimental medicine and biology. 572. 275–281. 3 indexed citations
2.
Yu, Cheng‐Rong, Rashid M. Mahdi, Samuel Ebong, et al.. (2004). Cell Proliferation and STAT6 Pathways Are Negatively Regulated in T Cells by STAT1 and Suppressors of Cytokine Signaling. The Journal of Immunology. 173(2). 737–746. 58 indexed citations
3.
Jackson, Sharon H., Cheng‐Rong Yu, Rashid M. Mahdi, Samuel Ebong, & Charles E. Egwuagu. (2004). Dendritic Cell Maturation Requires STAT1 and Is under Feedback Regulation by Suppressors of Cytokine Signaling. The Journal of Immunology. 172(4). 2307–2315. 137 indexed citations
4.
Ebong, Samuel, Cheng‐Rong Yu, Deborah Carper, Ana B. Chepelinsky, & Charles E. Egwuagu. (2004). Activation of STAT Signaling Pathways and Induction of Suppressors of Cytokine Signaling (SOCS) Proteins in Mammalian Lens by Growth Factors. Investigative Ophthalmology & Visual Science. 45(3). 872–872. 35 indexed citations
5.
Ebong, Samuel, Ana B. Chepelinsky, Michael L. Robinson, et al.. (2004). Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.. PubMed. 10. 122–31. 15 indexed citations
6.
Yu, Cheng‐Rong, Rashid M. Mahdi, Samuel Ebong, et al.. (2003). Suppressor of Cytokine Signaling 3 Regulates Proliferation and Activation of T-helper Cells. Journal of Biological Chemistry. 278(32). 29752–29759. 95 indexed citations
7.
Nemzek, Jean A., Samuel Ebong, Jiyoun Kim, G. Bolgos, & Daniel G. Remick. (2002). Keratinocyte Growth Factor Pretreatment Is Associated with Decreased Macrophage Inflammatory Protein-2?? Concentrations and Reduced Neutrophil Recruitment in Acid Aspiration Lung Injury. Shock. 18(6). 501–506. 43 indexed citations
8.
Wang, Xian, et al.. (2002). Calcitonin Gene-Related Peptide Partially Reverses Decreased Production of Chemokines KC and MIP-2 Following Murine Sepsis. Inflammation. 26(4). 167–174. 10 indexed citations
9.
Call, Douglas R., Jean A. Nemzek, Samuel Ebong, et al.. (2001). DIFFERENTIAL LOCAL AND SYSTEMIC REGULATION OF THE MURINE CHEMOKINES KC AND MIP2. Shock. 15(4). 278–284. 77 indexed citations
10.
Call, Douglas R., Jean A. Nemzek, Samuel Ebong, et al.. (2001). Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil Recruitment. American Journal Of Pathology. 158(2). 715–721. 90 indexed citations
11.
Remick, Daniel G., et al.. (2001). Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Critical Care Medicine. 29(3). 473–481. 62 indexed citations
12.
13.
Nemzek, Jean A., Douglas R. Call, Samuel Ebong, et al.. (2000). Immunopathology of a two-hit murine model of acid aspiration lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 278(3). L512–L520. 43 indexed citations
14.
Ebong, Samuel, Douglas R. Call, G. Bolgos, et al.. (1999). IMMUNOPATHOLOGIC RESPONSES TO NON-LETHAL SEPSIS. Shock. 12(2). 118–126. 86 indexed citations
15.
Granger, Jill, Daniel G. Remick, Douglas R. Call, et al.. (1999). A sandwich enzyme-linked immunoabsorbent assay for measurement of picogram quantities of murine granulocyte colony-stimulating factor. Journal of Immunological Methods. 225(1-2). 145–156. 4 indexed citations
16.
Call, Douglas R., et al.. (1999). SENSORY NEUROPEPTIDE CGRP, BUT NOT SP, POTENTIATES LPS-INDUCED CHEMOKINE KC SECRETION FROM THE MONO/MACROPHAGES IN MURINE SEPSIS. Shock. 11(Supplement). 86–86. 1 indexed citations
17.
Ebong, Samuel, Douglas R. Call, Jean A. Nemzek, et al.. (1999). Immunopathologic Alterations in Murine Models of Sepsis of Increasing Severity. Infection and Immunity. 67(12). 6603–6610. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026